3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
59
Thoracic
10
Breast
8
Gynecologic
7
NET
5
Head & Neck
5
Endocrine
5
Dermatologic
5
Genitourinary
4
Sarcoma
2
CNS
2
Other solid neoplasm
1
Other neoplasm
1
Lymphoid
1
Conditions
Brain Neoplasms
1899
Glioblastoma
1791
Glioma
1126
Central Nervous System Neoplasms
599
Astrocytoma
593
Neuroblastoma
552
Gliosarcoma
465
Oligodendroglioma
363
Neoplasms
312
Breast Neoplasms
273
Medulloblastoma
272
Carcinoma, Non-Small-Cell Lung
225
Recurrence
198
Sarcoma
183
Neoplasm Metastasis
183
Melanoma
181
Meningioma
177
Ependymoma
174
Lung Neoplasms
156
Lymphoma
133
Osteosarcoma
126
Meningeal Carcinomatosis
126
Neurofibromatosis 1
114
Wilms Tumor
111
Ovarian Neoplasms
110
Diffuse Intrinsic Pontine Glioma
105
Precursor Cell Lymphoblastic Leukemia-Lymphoma
103
Rhabdomyosarcoma
100
Lymphoma, Non-Hodgkin
96
Burkitt Lymphoma
89
Interventions
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Intestinal Neoplasms
×
CNS
×
Clear all
NCT04755920
2024-05-09
SGM-CBM
Leiden University Medical Center
Phase 2
Recruiting
10 enrolled
NCT04644315
2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2
Terminated
1 enrolled
5 charts